EyeGate Pharmaceuticals (NASDAQ:EYEG) Stock Sees High Volatility: What’s The Buzz?
Clinical-stage company developing and commercialising products for treating inflammatory diseases of eye and nervous system, EyeGate Pharmaceuticals (NASDAQ:EYEG) said on 28th July, 2021 that Brian M Strem, Ph.D., Co-Founder, Director and former Chief Executive Officer of Okogen, Incand Co-Founder and Managing Director of Bayon Therapeutics, will be the President, Chief Executive Officer and board member immediately. Stream has scientific acumen, strategic expertise as well as drug development experience in ophthalmology…